SAN DIEGO--(BUSINESS WIRE)--April 26, 2005--Aethlon Medical, Inc. (OTCBB:AEMD) announced that its Chairman & CEO, James A. Joyce, provided a corporate update during an interview with The Wall Street Reporter today. The interview can be accessed at www.wallstreetreporter.com through Thursday, April 28th. Mr. Joyce discussed Aethlon's upcoming HIV & HCV clinical trials, and detailed the Company's strategy to commercialize its Hemopurifier(TM) treatment technology as a first line of defense against drug and vaccine resistant bioweapons.
